Funds Holding Auxilium Pharmaceuticals, Inc.

 
Fund Quotes for Funds Holding Auxilium Pharmaceuticals, Inc. top ^
  • Holdings: Auxilium Pharmaceuticals Inc , Glacier Bancorp Inc , HMS Holdings Corp , KYTHERA Biopharmaceuticals Inc , Christopher & Banks Corp ,
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for ffscx investment picks
  • Holdings: Auxilium Pharmaceuticals Inc , Glacier Bancorp Inc , HMS Holdings Corp , KYTHERA Biopharmaceuticals Inc , Christopher & Banks Corp ,
  • Category: Small Growth
  • Morningstar Rating: 2 Stars
Sign-up for fscmx investment picks
  • Holdings: Auxilium Pharmaceuticals Inc , Glacier Bancorp Inc , HMS Holdings Corp , KYTHERA Biopharmaceuticals Inc , Christopher & Banks Corp ,
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for ffhix investment picks

 
Stock Quotes for Auxilium Pharmaceuticals, Inc. top ^
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for auxl investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for auxl investment picks

 
News Articles for Auxilium Pharmaceuticals, Inc. top ^
VANCOUVER, British Columbia, Oct.
Sign-up for QLT Announces Merger With Auxilium Pharmaceuticals, Inc. Terminates for Superior Proposal investment picks
Multiple Presentations Designed to Enable a Better Understanding of the Safety and Efficacy Profile of XIAFLEX for Treatment of Peyronie's Disease Additional Onset of Effect Study Results Expand Understanding of STENDRA for Treatment of Erectile Dysfunction CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. to Present XIAFLEX and STENDRA Data at SMSNA Scientific Meeting investment picks
$109.6 Million in 3Q 2014 Net Revenues Driven by Strong XIAFLEX Growth; Company Returns to Profitability with 3Q Non-GAAP EPS of $0.27 per Share CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results investment picks
2014/11/20
Peyronie's Disease Data Presented Enable a Better Understanding of the Safety and Efficacy of XIAFLEX for Treatment of PD; First Data Presented on PD Treatment Impact on Female Partner Sexual Function 2.
Sign-up for Auxilium Pharmaceuticals, Inc. Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting investment picks
Erectile Dysfunction Data Presented in Two Moderated Posters; Findings Enable a Better Understanding of the STENDRA Clinical Profile and Provide Additional Data Regarding the Use of STENDRA as Early as Approximately 15 Minutes Before Sexual Activity CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. Presents STENDRA Data At SMSNA Scientific Meeting investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Funds Holding Auxilium Pharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Autozone Inc  |  Next: Funds Holding Avago Technologies Ltd